Clinical Virologists specialize in the detection, monitoring, and analysis of viruses that cause human disease. They work in diagnostic laboratories, hospitals, and research institutions to identify viral infections such as influenza, HIV, hepatitis, and emerging threats like SARS-CoV-2. Using advanced molecular techniques like PCR, genome sequencing, and serological assays, they provide precise, timely diagnoses that guide clinical decision-making and infection control strategies. Their expertise is especially critical during viral outbreaks, when rapid identification and response can help contain the spread of disease. Accuracy in their findings is vital for minimizing delays in treatment and implementing public health measures.
Clinical Virologists contribute to public health surveillance, vaccine development, and the study of antiviral resistance. They work closely with epidemiologists, immunologists, and healthcare providers to track virus evolution, monitor vaccine effectiveness, and advise on appropriate therapeutic interventions. Their research supports the creation of new vaccines, treatments, and diagnostic tools tailored to evolving viral threats. As the landscape of infectious disease becomes more complex, Clinical Virologists play a frontline role in preparedness and response. Their work not only protects individual patients but also strengthens community-level defenses against future pandemics. Their insights continue to shape national and global strategies for managing viral diseases, reinforcing resilience in healthcare systems.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain